Virtual Diabetes "Boot Camp": An Innovative Model for Improving Glycemic Control

Area of Science:

• Endocrinology
• Digital Health
• Primary Care Medicine

Background:

• Telemedicine enhances patient-physician access and outcomes, particularly for chronic disease management.
• The COVID-19 pandemic accelerated telemedicine adoption, expanding its application in healthcare.
• An institution launched a 12-week telemedicine diabetes "boot camp" for uncontrolled diabetes patients.

Purpose of the Study:

• To evaluate the effectiveness of a telemedicine-based diabetes intervention program.
• To assess improvements in glycemic control and other health metrics in patients with poorly controlled diabetes.

Main Methods:

• Voluntary enrollment of 134 patients with diabetes mellitus (DM) and A1C > 8.0% from Sept 2020 to Nov 2021.
• Biweekly telemedicine visits conducted by dietitians and diabetes care specialists over 12 weeks.
• Measurement of demographics, A1C, BMI, and blood pressure pre- and post-intervention.

Main Results:

• A mean A1C reduction of -2.09% ± 2.4% was observed across all participants.
• A1C reduction was consistent across various demographics and clinic types.
• Higher initial A1C levels showed a negative correlation with A1C change, indicating greater improvement.

Conclusions:

• The telemedicine diabetes program effectively improved A1C in patients with poorly controlled diabetes.
• Intervention benefits were observed irrespective of patient characteristics.
• Initial glycemic severity was a predictor of greater A1C reduction.